ANALYSIS OF CLINICAL PROGNOSTIC FACTORS OF PD-1 IMMUNE CHECKPOINT INHIBITOR TREATMENT IN MALIGNANT MELANOMA AND CUTANEOUS SQUAMOUS CELL CARCINOMA

dc.contributor.advisor	Holló Péter
dc.contributor.author	Kuzmanovszki, Daniella
dc.date.accessioned	2025-06-03T12:40:01Z
dc.date.available	2025-06-03T12:40:01Z
dc.date.issued	2025
dc.identifier.uri	http://repo.lib.semmelweis.hu//handle/123456789/10122
dc.identifier.uri	doi:https://doi.org/10.14753/SE.2025.3128
dc.title	ANALYSIS OF CLINICAL PROGNOSTIC FACTORS OF PD-1 IMMUNE CHECKPOINT INHIBITOR TREATMENT IN MALIGNANT MELANOMA AND CUTANEOUS SQUAMOUS CELL CARCINOMA
dc.type	Dissertation
dc.date.updated	2025-05-12T09:20:53Z
dc.language.rfc3066	en
dc.rights.holder	NULL
dc.identifier.mtmt	36131586
dc.contributor.institution	Doktori Iskola
dc.contributor.institution	Bőr-, Nemikórtani és Bőronkológiai Klinika